Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 109 OP8.3 | DOI: 10.1530/endoabs.109.OP8.3

1MRC Laboratory of Medical Sciences, London, United Kingdom; 2Imperial College London, London, United Kingdom; 3Royal College of Surgeons in Ireland, Dublin, United Kingdom; 4University of Birmingham, Birmingham, United Kingdom; 5Imperial College Healthcare NHS Trust, London, United Kingdom; 6King’s College Hospital NHS Foundation Trust, London, United Kingdom; 7University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom; 8Hull University Teaching Hospitals NHS Trust, Hull, United Kingdom; 9Barts Health NHS Trust, London, United Kingdom; 10University of Edinburgh, Edinburgh, United Kingdom; 11Guy’s nd St Thomas’ NHS Foundation Trust, London, United Kingdom; 12Cardiff University, Cardiff, United Kingdom; 13King’s College London, London, United Kingdom; 14University of Warwick, Coventry, United Kingdom


Introduction: Population-based studies have suggested that women with polycystic ovary syndrome (PCOS) are at increased risk of obstructive sleep apnoea (OSA). We report the prevalence of high risk of OSA in a prospectively recruited cohort of women with PCOS and identified factors associated with increased OSA risk.

Methods: Women with PCOS diagnosed according to the Rotterdam criteria were prospectively recruited in a multi-centre study in 10 centres in the UK & Ireland. The Berlin and Epworth questionnaires were completed to screen participants for risk of OSA, The Berlin questionnaire stratifies the response into high-risk and low-risk categories. The Epworth utilises a cut-off of >7 to classify high-risk category. Logistic regression models were used to identify factors that are associated with increased risks of sleep disturbances in women with PCOS.

Results: A total of 726 women with PCOS were included in our analysis [Age 30 (26-34), BMI (31.1 (25.1-38.4)]. Prevalence of increased risk of OSA were 47.3% (n = 325/687) and 48.9% (n = 355/726) with Berlin and Epworth questionnaires, respectively. Independent of BMI, hyperandrogenism [aOR: 1.97 (1.0-3.8)], and alopecia [aOR: 1.7 (1.1-2.6)] were associated with increased odds of abnormal Berlin score. With Epworth score, hyperandrogenism [aOR: 1.8 (1.0-3.0)] and having irregular periods [aOR: 1.6 (1.0-2.7)] were associated with an abnormal score, also after adjustment for BMI.

Conclusion: Independent of BMI, women with PCOS score highly on Epworth and Berlin scores, indicating increased risk of OSA. These results highlight the importance of screening for OSA in women with PCOS, regardless of BMI. Hyperandrogenism increased the odds of OSA. Thus, the role of androgens in the pathogenesis of OSA requires further study.

Volume 109

Society for Endocrinology BES 2025

Harrogate, UK
10 Mar 2025 - 12 Mar 2025

Society for Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches